Simplify Logo

Full-Time

Human Resources Service Delivery Lead

Posted on 9/5/2024

Tessera Therapeutics

Tessera Therapeutics

201-500 employees

Develops gene editing technology for genetic medicine

Data & Analytics
Hardware
Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

Category
Human Resources
People & HR
Required Skills
Management
Human Resources Information System (HRIS)
Requirements
  • Bachelor’s degree (Business or Human Resources preferred)
  • 7+ years overall HR/Operations experience, with 3+ years being within a People Operations, HR Shared Services or Project/Program Management role
  • Leading a best-in-class Employee Experience HR support model for the full employee lifecycle from Onboarding, Talent Management, Growth & Development, Life Events through to Offboarding.
  • Building a Documentation/Knowledge Management framework to support a streamlined employee experience and internal process controls.
  • HRIS Data Management, experience with UKG Pro preferred
  • Driving efficiency and innovation within the organization utilizing HR systems to deliver value to employees and internal stakeholders cross-functionally
  • Independent analytical and problem-solving, with a high attention to detail and accuracy.
  • Facilitating employee immigration matters, preferred
  • Intermediate to Advanced Microsoft Office skills and SharePoint
Responsibilities
  • Supporting employees throughout their employment journey with empathy and care
  • Enhancing the HR Service Delivery Model (SDM) by proactively and tenaciously seeking out and implementing improvements through digital solutions that drive organizational value
  • Collaborating across the organization to identify and address knowledge gaps, streamline processes, and foster continuous learning and improvement
  • Creating and presenting information in an effective, user-friendly manner, while maintaining a focus on compliance
  • Leading the implementation of an HR ticketing and knowledge management system to improve the Employee Experience and support a robust self-service model
  • Monitoring, analyzing, and presenting data to demonstrate the impact and effectiveness of our HR SDM at all organizational levels.
  • Working with agility to support the team across all aspects of service delivery
  • Thriving in a fast-paced environment while fostering a culture of collaboration, innovation, excellence and community.

Tessera Therapeutics focuses on genetic medicine, utilizing a technology called Gene Writing to make precise changes to the human genome. This technology allows for permanent alterations to genetic material in any cell, which can potentially cure diseases at their source. The Gene Writing platform can perform both small and large genetic modifications, making it applicable to a wide range of genetic disorders. Tessera Therapeutics collaborates with research institutions, pharmaceutical companies, and healthcare providers to develop new treatments for genetic diseases. Unlike many competitors, Tessera's approach emphasizes the ability to address previously untreatable conditions through its proprietary technology. The company's goal is to advance the development of Gene Writing to ultimately cure diseases by rewriting the genetic code.

Company Stage

Series C

Total Funding

$581.7M

Headquarters

Cambridge, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

-7%

1 year growth

-3%

2 year growth

26%
Simplify Jobs

Simplify's Take

What believers are saying

  • Tessera's innovative Gene Writing technology has the potential to cure previously untreatable genetic conditions, offering a transformative impact on healthcare.
  • The company's strategic partnerships and licensing agreements with major pharmaceutical firms and research institutions can drive significant revenue growth and market penetration.
  • Recent leadership appointments, including a new General Counsel and Chief Regulatory Officer, bring extensive industry experience that can guide the company through regulatory and commercial milestones.

What critics are saying

  • The highly competitive biotechnology sector requires continuous innovation to maintain Tessera's market position.
  • Regulatory hurdles and the complexity of clinical trials for genetic therapies could delay product development and commercialization.

What makes Tessera Therapeutics unique

  • Tessera Therapeutics' Gene Writing technology offers a unique capability to make precise and permanent genetic alterations, setting it apart from traditional gene editing methods.
  • The company's focus on a wide range of genetic disorders, from phenylketonuria to sickle cell disease, showcases the versatility and broad applicability of its platform.
  • Securing $300 million in Series C financing highlights strong investor confidence and provides substantial resources for advancing their groundbreaking technology.